Copenhagen Symposium on Separation Sciences (CSSS) Event Preview
The Column
The 2nd Copenhagen Symposium on Separation Sciences (CSSS 2018) will be held on 26–27 June 2018 at the DGI-byen in Copenhagen, Denmark. The preliminary programme of the 2nd CSSS is summarized below and gives an idea of what can be expected.
Photo Credit: Bucchi Francesco/Shutterstock.com
Jörg Kutter1, Bente Gammelgaard1, Inga Bjørnsdottir2, Carsten Boye Knudsen3, and Stig Pedersen-Bjergaard1,4,1Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark, 2Novo Nordisk, Måløv, Denmark, 3Zealand Pharma, Glostrup, Denmark, 4School of Pharmacy, University of Oslo, Oslo, Norway
The 2nd Copenhagen Symposium on Separation Sciences (CSSS 2018) will be held on 26–27 June 2018 at the DGI-byen in Copenhagen, Denmark. The preliminary programme of the 2nd CSSS is summarized below and gives an idea of what can be expected.
Analytical separation sciences-including chromatography, electrophoresis, mass spectrometry, and sample preparation-play a vital role in the pharmaceutical industry, and the implementation of new concepts, technologies, and applications is a continuous process to support discovery, development, and manufacture of pharmaceutical products. While the analytical applications are developed by the pharmaceutical industry, the new analytical concepts and technologies are traditionally developed by vendors and academia. Strong scientiï¬c interactions between the pharmaceutical industry, academia, and vendors are therefore very important, and this is the purpose of the Copenhagen Symposium on Separation Sciences (CSSS). CSSS is a twoâday symposium where separation scientists from the pharmaceutical industry, academia, and vendors interact and discuss separation science.
The scientiï¬c programme is designed to be highly attractive for both industry and academia. The programme will comprise 18 invited plenary lectures by internationally leading separation scientists, submitted posters presented by participants, discussion sessions, and a symposium dinner. In addition, an exhibition of instruments, equipment, and consumables is an important and integrated part of the scientiï¬c programme. The talks by leading scientists will provide perspective, fundamentals, insight, and glimpses of how the field of separation sciences is developing.
Scientific sessions will include: the longâterm perspective; recent progress in liquid-phase chromatography and electrophoresis; recent progress in microfluidics; recent progress in immunoaffinity techniques; forefront applications of mass spectrometry; forefront biopharmaceutical characterization; and ADME and pharmacometabolomics. Confirmed speakers include: Michael Lämmerhofer; Gert Desmet; Peter Myers; Frantisek Foret; Alberto Cavazzini; Detlev Belder; Myriam Taverna; Trine Grønhaug Halvorsen; Kevin Pagel; Petur Weihe Dalsgaard; Deirdre Cabooter; Isabelle Kohler; Christian Janfelt; Davy Guillarme; Elena Dominguez Vega; and Nikoline Juul Nielsen.
The first CSSS was organized in June 2016 with close to 100 participants. This successful symposium was initiated by Steen Honoré Hansen from the University of Copenhagen. Steen was a pioneer in separation sciences applied to pharmaceutics, but he unfortunately passed away on 31 October 2017. The CSSS series will be organized to honour Steen and his great contribution to separation sciences and pharmaceutical chemical analysis.
The CSSS series is internationally oriented and the symposium language is English. CSSS is a biannual event in June in the beautiful city of Copenhagen. Copenhagen has a very strong pharmaceutical base in the area, and is also nicknamed Medicon Valley. Medicon Valley is currently one of Europe’s top three sites for biotech innovation alongside Cambridge in the UK, and Basel in Switzerland. The Medicon Valley hub comprises the area of eastern Denmark and south-western Sweden connected via the Oresund Bridge. It is home to a large number of life science and pharmaceutical companies and research institutions located within a very small geographical area. Medicon Valley hosts a total of 12 universities, including the University of Copenhagen and the Technical University of Denmark. Danish pharmaceutical giants such as Novo Nordisk and Lundbeck all have research centres in the region.
The Copenhagen Symposium on Separation Sciences 2018 will take place in the modern facilities of DGI-byen in the heart of Copenhagen, within walking distance of the Central Station. The Central Station can be reached in 20 min by train from the international airport of Copenhagen.
The members of the scientific committee are Jörg P. Kutter (Chairman, University of Copenhagen), Bente Gammelgaard (University of Copenhagen), Inga Bjørnsdottir (Novo Nordisk), Carsten Boye Knudsen (Zealand Pharma), and Stig PedersenâBjergaard (University of Oslo, University of Copenhagen).
The organizers warmly welcome participants from industry and academia, working with pharmaceuticals or not, but with interest in analytical separation science, to join the symposium.
E-mail: contact@cphsss.org
Website:https://cphsss.org/
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
